多西他赛联合奈达铂治疗晚期食管癌的临床分析(1)
[摘要]目的 观察多西他赛联合奈达铂一线治疗晚期食管癌的疗效和不良反应。方法 选取2013年3月~2015年11月我院收治的54例晚期食管癌患者,随机分为两组,每组27例。治疗组给予多西他赛联合奈达铂治疗,对照组给予多西他赛联合顺铂治疗。治疗2个周期后评价疗效,观察不良反应。结果 治疗组和对照组患者的有效率分别为55.56%和48.15%,疾病控制率分别为85.19%和81.48%,两组比较差异均无统计学意义(P>0.05)。不良反应主要为呕吐、白细胞减少、血小板减少、肾功能异常,治疗组不良反应程度较对照组明显减轻(P<0.05)。结论 多西他赛联合奈达铂治疗晚期食管癌与多西他赛联合顺铂比较,疗效相当,不良反应轻,患者耐受性好。
[关键词]奈达铂;多西他赛;晚期食管癌;化学治疗
[中图分类号] R735.1 [文献标识码] A [文章编号] 1674-4721(2016)11(c)-0098-03
[Abstract]Objective To observe the curative effect and adverse reaction of Docetaxel combined with Nedaplatin in treatment of advanced esophageal cancer.Methods Fifty-four patients with advanced esophageal from March 2013 to November 2015 were randomly divided into two groups.The patients in treatment group were given Docetaxel combined with Nedaplatin ......
您现在查看是摘要页,全文长 3673 字符。
[关键词]奈达铂;多西他赛;晚期食管癌;化学治疗
[中图分类号] R735.1 [文献标识码] A [文章编号] 1674-4721(2016)11(c)-0098-03
[Abstract]Objective To observe the curative effect and adverse reaction of Docetaxel combined with Nedaplatin in treatment of advanced esophageal cancer.Methods Fifty-four patients with advanced esophageal from March 2013 to November 2015 were randomly divided into two groups.The patients in treatment group were given Docetaxel combined with Nedaplatin ......
您现在查看是摘要页,全文长 3673 字符。